CRISPR Therapeutics AG CRSP
45.74 USD -4.30 (-8.59%)
Nov 10, 2026, 12:52 PM EST
45.51 Day range 49.29
44.12 52-week range 63.45
- YTD
- -12.78%
- 1 year
- -16.20%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.51M | 37.31M | 371.21M | 1.20M | 914.96M | |
| 3.51M | 37.31M | 371.21M | 1.20M | 914.96M | |
| -664.57M | -466.57M | -222.54M | -673.16M | 373.53M | |
| -581.60M | -366.25M | -153.61M | -650.17M | 377.66M | |
| -6.47 | -4.34 | -1.94 | -8.36 | 4.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 355.19M | 309.78M | 401.07M | 223.52M | 939.94M | |
| 2.27B | 2.24B | 2.23B | 2.24B | 2.75B | |
| 343.43M | 309.95M | 346.77M | 367.58M | 352.42M | |
| 206.75M | 223.69M | 238.63M | 244.02M | 225.03M | |
| 1.92B | 1.93B | 1.88B | 1.88B | 2.40B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -345.01M | -142.77M | -260.38M | -495.74M | 538.97M | |
| -31.80M | -280.48M | 374.65M | -258.65M | -1.04B | |
| 426.03M | 331.98M | 62.66M | 38.59M | 250.94M | |
| -914.00K | -1.90M | -9.47M | -37.19M | -81.70M | |
| 49.30M | -91.29M | 177.01M | -715.88M | -245.52M |